+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Cost-benefit analysis of mammography screening in Denmark based on discrete ranking data

Cost-benefit analysis of mammography screening in Denmark based on discrete ranking data

International Journal of Technology Assessment in Health Care 16(3): 811-821

Economic evaluations such as cost-effectiveness and cost-utility analyses generally fail to incorporate elements of intangible costs and benefits, such as anxiety and discomfort associated with the screening test and diagnostic test, as well as the magnitude of utility associated with a reduction in the risk of dying from cancer. This paper seeks to include all costs and effects incurred by introducing mammography screening through the application of discrete ranking modeling. In the present analysis, 207 women were interviewed and asked to rank, according to priority, a number of alternative breast cancer screening setups. The alternative programs varied with respect to number of tests performed, risk reduction obtained, probability of a false-positive outcome, and extent of copayment. Using discrete ranking modeling, the stated preferences were analyzed and the relative weighting of the program attributes identified. For a range of hypothetical breast cancer programs, relative utilities and corresponding willingness-to-pay estimates were derived. A comparison of cost and willingness to pay for each of the programs suggested that net benefits are maximized when screening person aged 50-74 years biennially. More intensive screening produces lower or similar levels of utility at a higher cost. Discrete ranking modeling can aid decision making by identifying inferior healthcare programs, i.e., programs that are more costly but less beneficial.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 045661528

Download citation: RISBibTeXText

PMID: 11028136

DOI: 10.1017/s0266462300102089

Related references

Cost-benefit analysis in mammography screening. Der Radiologe 36(4): 300-305, 1996

Excellent results of mammography screening. Still balancing between cost-benefit analysis. Lakartidningen 95(18): 2042, 1998

Cost-benefit analysis of a mammography screening program extended to all the national territory. Epidemiologia E Prevenzione 21(2): 118-128, 1997

Flawed inferences about screening mammography's benefit based on observational data. Journal of Clinical Oncology 27(4): 639, 2009

Cost-benefit analysis of population screening for abdominal aortic aneurism, based on five-year results of a randomised hospital-based screening trial. Ugeskrift for Laeger 168(34): 2817-2819, 2006

Cost-benefit determinations in screening mammography. Cancer 60(7 Suppl): 1680-1683, 1987

Biology and cost-benefit in mammography screening. Acta Oncologica 36(7): 673-674, 1997

Discrepancies between multicriteria decision analysis-based ranking and intuitive ranking for pharmaceutical benefit-risk profiles in a hypothetical setting. Journal of Clinical Pharmacy and Therapeutics 42(1): 80-86, 2017

Cost implications of routine mammography screening of women 50-69 years in the county of Funen, Denmark. Health Policy 54(2): 125-141, 2000

Budget impact analysis of switching to digital mammography in a population-based breast cancer screening program: a discrete event simulation model. Plos one 9(5): E97459, 2014

School-based screening for tuberculous infection. A cost-benefit analysis. JAMA 274(8): 613-619, 1995

Secondary Analysis of Economic Data: A Review of Cost-Benefit Studies of Neonatal Screening for Phenylketonuria. Journal of Epidemiology and Community Health (1979-) 53(3): 179-186, 1999

Secondary analysis of economic data: a review of cost-benefit studies of neonatal screening for phenylketonuria. Journal of Epidemiology and Community Health 53(3): 179-186, 1999

Risk-benefit analysis for mass screening of breast cancer utilizing mammography as a screening test. Nihon Igaku Hoshasen Gakkai Zasshi. Nippon Acta Radiologica 49(9): 1091-1095, 1989

Breast Cancer Mortality Reduction in the United States Between 1969-2009 Was Independent of Screening Mammography in the 9 Geographically Disperse SEER Regions: More Evidence for Less Benefit of Screening Mammography. International Journal of Radiation Oncology*biology*physics 87(2): S493-S494, 2013